Order Article Reprints

Kong JH, Winton EF, Heffner LT, Gaddh M, Hill B, Neely J, Hatcher A, Joseph M, Arellano M, El-Rassi F, et al. Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors. Journal of Clinical Medicine. 2020; 9(5):1542. https://doi.org/10.3390/jcm9051542

Kong, Jee Hyun, Elliott F. Winton, Leonard T. Heffner, Manila Gaddh, Brittany Hill, Jessica Neely, Angela Hatcher, Meena Joseph, Martha Arellano, Fuad El-Rassi, and et al. 2020. "Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors" Journal of Clinical Medicine 9, no. 5: 1542. https://doi.org/10.3390/jcm9051542

Kong, J. H., Winton, E. F., Heffner, L. T., Gaddh, M., Hill, B., Neely, J., Hatcher, A., Joseph, M., Arellano, M., El-Rassi, F., Kim, A., Khoury, J. H., & Kota, V. K. (2020). Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors. Journal of Clinical Medicine, 9(5), 1542. https://doi.org/10.3390/jcm9051542